+49 30 648 35 164 service@chameleon-pharma.com

Colombia banning animal testing in cosmetics. How can this positively impact your business abroad?

Being the first country in Latin America to create public policies on this matter, Colombia will probably influence its neighboring countries to move in the same direction which can have a positive impact on your business.

In a historical decision, the Colombian Congress approved a law that bans animal testing for cosmetics and personal care products. The text, to be signed by President Ivan Duque, prohibits “the experimentation, import, export, manufacture, and marketing of cosmetic products, their ingredients or combinations of them” that have been tested on animals after its entry into force. This new law, however, does not affect animal testing for medical purposes.

In addition to financial penalties, the new legislation supports campaigns against testing cosmetics on animals, and incentives for laboratories that develop and apply alternative testing models. Companies will have four years to adapt their processes to comply with the new law.

This law will heavily affect trade with countries where animal testing is mandatory, such as China for example. On the other hand, this can be particularly interesting for companies interested in a market entry in Columbia, and can even facilitate trade with the European market, where a law similar to the Colombian one already applies.

Being the 3rd most important beauty and personal care market in Latin America, sales in Colombia are expected to reach US$5,14 million by 2030. We can help you build a solid market entry strategy to take advantage of this opportunity or support you in product registration. Click here for more information.

Featured image: Photo by Towfiqu barbhuiya on Unsplash

Contact us

8 + 12 =

Related Posts

Meet CPC at expopharm Munich 2026: Explore Pharmacy and

Meet CPC at expopharm Munich 2026: Explore Pharmacy and

Meet Chameleon Pharma Consulting CEO Reiner Christensen at expopharm Munich from 15–17 September 2026. Arrange an individual meeting to discuss pharmacy trends, international market entry, partner identification, and consumer healthcare opportunities.

Mexico’s New Fast-Track Drug & Medical Device Registration

Mexico’s New Fast-Track Drug & Medical Device Registration

Mexico is reshaping its COFEPRIS registration system with a new abbreviated Reliance pathway for eligible drugs and Medical Devices. With review targets of 45 business days for medicines and CPC Fast-Track registration strategies targeting approximately 10–15 months, the new framework creates important opportunities for faster market entry.

Our services

i

International Company Partner Identification

Licensing and
M&A

Product Potential & Country Analysis

International Business & Market Entry

U

Pharma Regulatory & Registration

Pharma Executive
Search

International Strategy & Analysis

Market Reports and Analysis